TEM is trading 4.3% up today at $60.40 as strong Q1 2026 results and AI healthcare optimism extend a multi-day rally from the mid-$40s.
- The company reported 36% year-over-year revenue growth and a meaningful EPS beat, driving renewed confidence in its data-driven platform.
- Investors are repricing the stock amid broader enthusiasm for AI-enabled life sciences tools and sustained post-earnings momentum.